Pharma News

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.

Boehringer Ingelheim breaks into oncology with FDA approval for lung cancer med Hernexeos

Genmab and AbbVie’s subcutaneous bispecific antibody Epkinly (epcoritamab) has met its dual primary endpoints as a second-line combination therapy in relapsed or refractory (r/r) fol...

On August 6, 2025 the FDA granted accelerated approval to dordaviprone (Modeyso; Jazz Pharmaceuticals), for use in adult and pediatric patients with H3 K27M-mutant diffuse midline glioma and w...

The FDA expands tocilizumab-anoh's approval for treating cytokine release syndrome (CRS), enhancing treatment options for patients aged 2 and older.

An outbreak of Legionnaires' disease in New York City has killed two people and sickened 58 since late July.

Boosting enzyme in brain immune cells could help treat Alzheimer's disease

Shares of Vertex Pharmaceuticals sank 15% soon after the opening bell Tuesday, Aug. 5, 2025.

As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company is moving to offload another plant with a checkered past.

Novavax’s H5N1 avian influenza vaccine candidate shows a robust immune response with 1- and 2-dose intranasal or intramuscular administration for nonhuman primates.

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Would you like a reduction in the prices that you pay for medications? How about a 30% to 40% reduction?